BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 36043497)

  • 1. Development of a holistic communication score (HoCoS) in patients treated for oral or oropharyngeal cancer: Preliminary validation.
    Balaguer M; Pinquier J; Farinas J; Woisard V
    Int J Lang Commun Disord; 2023 Jan; 58(1):39-51. PubMed ID: 36043497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dutch translation and validation of the Communicative Participation Item Bank (CPIB)-short form.
    van Sluis KE; Passchier E; van Son RJJH; van der Molen L; Stuiver M; van den Brekel MWM; Van den Steen L; Kalf JG; van Nuffelen G
    Int J Lang Commun Disord; 2023 Jan; 58(1):124-137. PubMed ID: 36063423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the French Versions of the Speech Handicap Index and the Phonation Handicap Index in Patients Treated for Cancer of the Oral Cavity or Oropharynx.
    Balaguer M; Farinas J; Fichaux-Bourin P; Puech M; Pinquier J; Woisard V
    Folia Phoniatr Logop; 2020; 72(6):464-477. PubMed ID: 31734664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Preliminary Validation of the Questionnaire "Evaluation of the Constitution of Social Circles" in Patients Treated for Cancer of the Upper Aerodigestive Tract.
    Balaguer M; Pommée T; Pinquier J; Farinas J; Woisard V; Sordes F
    Folia Phoniatr Logop; 2023; 75(1):52-66. PubMed ID: 35665696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Patient-Centered Functional Outcomes Questionnaire in Head and Neck Cancer.
    Mendez A; Seikaly H; Eurich D; Dzioba A; Aalto D; Osswald M; Harris JR; O'Connell DA; Lazarus C; Urken M; Likhterov I; Chai RL; Rauscher E; Buchbinder D; Okay D; Happonen RP; Kinnunen I; Irjala H; Soukka T; Laine J;
    JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):437-443. PubMed ID: 32271362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Mexican Spanish version of the EORTC QLQ-H&N35 instrument to measure health-related quality of life in patients with head and neck cancers.
    Carrillo JF; Ortiz-Toledo MA; Salido-Noriega Z; Romero-Ventura NB; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Ann Surg Oncol; 2013 May; 20(5):1417-26. PubMed ID: 23108555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Communicative Participation and Quality of Life in Pretreatment Oral and Oropharyngeal Head and Neck Cancer.
    Sauder C; Kapsner-Smith M; Baylor C; Yorkston K; Futran N; Eadie T
    Otolaryngol Head Neck Surg; 2021 Mar; 164(3):616-623. PubMed ID: 32928035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).
    Sherman AC; Simonton S; Adams DC; Vural E; Owens B; Hanna E
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):459-67. PubMed ID: 10772298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties of the Urdu version of the EORTC QLQ-H&N35 (European organization for research and treatment of cancer head and neck module) quality of life tool.
    Zahid N; Martins RS; Zahid W; Azam I; Ikram M; Hassan A; Bhamani SS; Jabbar AA; Asad N; Akhtar S; Siddiqui MI; Awan MS; Ahmad K
    BMC Psychol; 2022 Aug; 10(1):194. PubMed ID: 35934706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.
    Bjordal K; Hammerlid E; Ahlner-Elmqvist M; de Graeff A; Boysen M; Evensen JF; Biörklund A; de Leeuw JR; Fayers PM; Jannert M; Westin T; Kaasa S
    J Clin Oncol; 1999 Mar; 17(3):1008-19. PubMed ID: 10071296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supportive care among head and neck cancer patients: An initial validation of the Dutch version of the Performance Status Scale for Head and Neck Cancer (D-PSS-HN).
    Baudelet M; Van den Steen L; Wouters S; De Bodt M; Vanderveken O; Duprez F; Van Nuffelen G
    Int J Lang Commun Disord; 2023; 58(5):1668-1679. PubMed ID: 37189297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka.
    Kosgallana S; Jayasekara P; Abeysinghe P; Hjermstad M; Lalloo R
    BMC Oral Health; 2022 Aug; 22(1):359. PubMed ID: 35986341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speech Handicap Index in patients with oral and pharyngeal cancer: better understanding of patients' complaints.
    Rinkel RN; Verdonck-de Leeuw IM; van Reij EJ; Aaronson NK; Leemans CR
    Head Neck; 2008 Jul; 30(7):868-74. PubMed ID: 18302270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of an automatic score for the evaluation of speech disorders among patients treated for a cancer of the oral cavity or the oropharynx: The Carcinologic Speech Severity Index.
    Woisard V; Balaguer M; Fredouille C; Farinas J; Ghio A; Lalain M; Puech M; Astesano C; Pinquier J; Lepage B
    Head Neck; 2022 Jan; 44(1):71-88. PubMed ID: 34729847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study.
    Borggreven PA; Verdonck-de Leeuw IM; Muller MJ; Heiligers ML; de Bree R; Aaronson NK; Leemans CR
    Eur Arch Otorhinolaryngol; 2007 Jun; 264(6):651-7. PubMed ID: 17273840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the oral health impact profile - 14 in patients with head and neck cancer.
    Tesic M; Cankovic M; Jevtic M; Stevanovic D
    Med Oral Patol Oral Cir Bucal; 2020 Nov; 25(6):e739-e744. PubMed ID: 32388514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17.
    Yekaninejad MS; Pakpour AH; Tadakamadla J; Kumar S; Mosavi SH; Fridlund B; Bottomley A; Aaronson NK
    Support Care Cancer; 2015 May; 23(5):1215-24. PubMed ID: 25312650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life after different treatment modalities for carcinoma of the oropharynx.
    Tschudi D; Stoeckli S; Schmid S
    Laryngoscope; 2003 Nov; 113(11):1949-54. PubMed ID: 14603054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.